Full-exon pyrosequencing screening of BRCA germline mutations in Mexican women with inherited breast and ovarian cancer. - Test2 - elhamkhani - TriplyDB

Full-exon pyrosequencing screening of BRCA germline mutations in Mexican women with inherited breast and ovarian cancer.

Full-exon pyrosequencing screening of BRCA germline mutations in Mexican women with inherited breast and ovarian cancer.

http://www.wikidata.org/entity/Q34288968

about

Cracking the Code of Human Diseases Using Next-Generation Sequencing: Applications, Challenges, and Perspectives Next generation sequencing applications for breast cancer research.Founder and Recurrent Mutations in BRCA1 and BRCA2 Genes in Latin American Countries: State of the Art and Literature Review.Significant clinical impact of recurrent BRCA1 and BRCA2 mutations in Mexico.Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from Peru.Recurrent BRCA1 and BRCA2 mutations in Mexican women with breast cancer The prevalence of BRCA1 and BRCA2 mutations among young Mexican women with triple-negative breast cancer The spectrum of BRCA1 and BRCA2 alleles in Latin America and the Caribbean: a clinical perspective Genomic Disparities in Breast Cancer Among Latinas.Prevalence and impact of founder mutations in hereditary breast cancer in Latin America.Genetic Cancer Risk Assessment for Breast Cancer in Latin America.A comprehensive focus on global spectrum of BRCA1 and BRCA2 mutations in breast cancer.Mutations in BRCA1, BRCA2 and other breast and ovarian cancer susceptibility genes in Central and South American populations.Nonoptical massive parallel DNA sequencing of BRCA1 and BRCA2 genes in a diagnostic setting.Description of Genetic Variants in Genes in Mexican Patients with Ovarian Cancer: A First Step towards Implementing Personalized Medicine

P2860

Q26776038-0B035686-6A5F-4850-99ED-072398BD93D3 Q27690994-C6990F5D-5663-483B-8633-FA210D14793C Q34530426-B0F978D2-197B-4FCE-9CD2-6817B8F0E920 Q35007651-EDA21508-7613-4EC0-88F7-6F2323ED4AB0 Q35217775-7CAD414E-7361-4340-97B7-88D6D86F2565 Q35830539-C481B63C-1972-4C95-A38A-A39EF6E0FCCA Q35940364-E2059B33-668A-4952-A6AB-1FA75BC02ADE Q36322846-047E3F04-9EF0-45AD-8A13-82832869D75C Q37509093-D8C1D12E-60E5-47AD-97AE-057C056458E7 Q37697803-5FA176A6-1BB4-473A-BF73-D6ECE2E7D0A6 Q38814664-EB49F2C2-5082-4E07-8EE0-9504F8F7CF6D Q42181679-CD7969CA-5326-4BED-A71C-8F3895939B08 Q49553408-CED67438-849F-4A8E-B545-6FC810DB3081 Q51838415-D6C2B195-3FE7-4D36-AF0E-AFEA53681001 Q58795187-62394007-7A50-40AF-8811-E0B14F2CEBFE

P2860

Full-exon pyrosequencing screening of BRCA germline mutations in Mexican women with inherited breast and ovarian cancer.

http://www.wikidata.org/entity/Q34288968

description

2012 nî lūn-bûn

@nan

2012 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Full-exon pyrosequencing scree ...... ted breast and ovarian cancer.

@ast

Full-exon pyrosequencing scree ...... ted breast and ovarian cancer.

@en

Full-exon pyrosequencing scree ...... ted breast and ovarian cancer.

@nl

type

label

Full-exon pyrosequencing scree ...... ted breast and ovarian cancer.

@ast

Full-exon pyrosequencing scree ...... ted breast and ovarian cancer.

@en

Full-exon pyrosequencing scree ...... ted breast and ovarian cancer.

@nl

prefLabel

Full-exon pyrosequencing scree ...... ted breast and ovarian cancer.

@ast

Full-exon pyrosequencing scree ...... ted breast and ovarian cancer.

@en

Full-exon pyrosequencing scree ...... ted breast and ovarian cancer.

@nl

P1433

Q34288968-5E8D265B-CF4D-40A9-B8BD-3642BA1CCCB8

P1476

Q34288968-7DFDA019-D2CB-47C6-9ED4-96F97D19147E

P2093

Q34288968-12F71856-426C-4132-89DB-A3E4F10DCC91

Q34288968-35538B58-963E-4A13-9F5F-83E2873DE3FE

Q34288968-3838A9DE-FFB3-433C-B9F3-E19CBF2EA96A

Q34288968-3AC92978-F691-4F3A-A457-9985B996F933

Q34288968-6262755B-E0D9-4F88-A201-2C890C980BF3

Q34288968-B9CFB3C3-A801-4B36-ADD8-2C0FE69E9D76

Q34288968-BC0B8A2B-01BC-4693-82F1-9C106945BCDC

Q34288968-DA798FC1-966F-481B-B9F5-5088EB576A2D

Q34288968-F4921690-904E-4ED9-A9A7-E7A7C61B8DFC

P2860

Q34288968-02DFEB41-84B3-4051-B828-6FC621D7F177

Q34288968-064E1237-EABF-416B-AFD7-994CD81ECEAF

Q34288968-14CDFC84-A1EB-4A2F-A8F8-28F8A0FB5660

Q34288968-1737F156-BEF8-4843-B794-0E4DABFE4FFE

Q34288968-1F0CA77D-154E-488F-8794-EA90A3F1EA48

Q34288968-278E4427-5014-4B5F-8A18-49723DD8D2A3

Q34288968-36C13D7D-6511-49E2-B40D-3A54DBE367A3

Q34288968-3F25EC02-05EF-4BB3-AD9D-24C12CA0017A

Q34288968-45D57034-E2B9-4991-9187-626665B17B9C

Q34288968-45F378D4-40F9-4C23-87D7-86403DFE13D3

P304

Q34288968-95AFCCB5-41B8-4B17-BE37-26EBB8B322F3

P31

Q34288968-71C19959-300E-4889-8500-D9E71254F09C

P356

Q34288968-8F708B92-EF65-47F8-9989-D7F8AF38D269

P407

Q34288968-C2524A2F-23B8-4D7F-A145-25789ED1C88C

P433

Q34288968-0C17EA96-5E49-40C4-8161-0B92DA4130BF

P478

Q34288968-15ACEE5C-E598-47EB-B42B-4357C4BD79C5

P50

Q34288968-78A05951-D699-4D16-95D9-6B8125429EB7

P577

Q34288968-3D0CDD5F-323C-4575-A136-C51932E25420

P5875

Q34288968-DD94B3FA-E399-4A10-8109-BDF0B5FAD305

P698

Q34288968-8137E93D-38A4-4D88-99BD-4273817A12F7

P921

Q34288968-DCA147ED-5EB9-42F7-A19C-BA9091137966

P932

Q34288968-60F204FB-63C6-4B01-947F-F6AC2E4BC91F

P356

JOURNAL.PONE.0037432

P1433

P1476

Full-exon pyrosequencing scree ...... ted breast and ovarian cancer.

@en

P2093

Alejandro Mohar

http://www.w3.org/2001/XMLSchema#string

César López-Camarillo

http://www.w3.org/2001/XMLSchema#string

David Cantú

http://www.w3.org/2001/XMLSchema#string

Enrique Bargallo-Rocha

http://www.w3.org/2001/XMLSchema#string

Felipe Vaca-Paniagua

http://www.w3.org/2001/XMLSchema#string

Luis Alonso Herrera

http://www.w3.org/2001/XMLSchema#string

Rosa María Alvarez-Gomez

http://www.w3.org/2001/XMLSchema#string

Silvia Vidal-Millan

http://www.w3.org/2001/XMLSchema#string

Verónica Fragoso-Ontiveros

http://www.w3.org/2001/XMLSchema#string

P2860

Contribution of BRCA1 and BRCA2 mutations to breast and ovarian cancer in Pakistan

Meta-analysis of BRCA1 and BRCA2 penetrance

Pathogenicity of the BRCA1 missense variant M1775K is determined by the disruption of the BRCT phosphopeptide-binding pocket: a multi-modal approach

Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor

Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial

Characterization of BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE study.

Accuracy and quality assessment of 454 GS-FLX Titanium pyrosequencing.

Contribution of germline BRCA1 and BRCA2 sequence alterations to breast cancer in Northern India.

Variation in cancer risks, by mutation position, in BRCA2 mutation carriers.

P304

e37432

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0037432

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Carlos Pérez-Plasencia

P577

2012-05-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

225087246

http://www.w3.org/2001/XMLSchema#string

P698

22655046

http://www.w3.org/2001/XMLSchema#string

P921

P932

3360054

http://www.w3.org/2001/XMLSchema#string